Harvard Heart Letter

State-of-the-heart therapy for prostate cancer

New research suggests a two-way street between hormone therapy for prostate cancer and heart disease.

The terms "prostate cancer" and "heart disease" aren't usually uttered in the same breath. But maybe they should be, especially for the growing number of men whose prostate cancer is treated with testosterone-lowering hormone therapy.

Each year, about 220,000 American men learn they have prostate cancer. As cancers go, it can be a slowpoke, usually taking years to spread through the walnut-sized gland and break out into nearby tissues. Although the disease kills about 27,000 men each year, most men who have prostate cancer die of other things, often from heart disease.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »